Sentimet, none - disclosure, not held - profile not availbee, page-28

First 28 Last

Share
Profile

Follow
Alway

7,264 Posts.

694

04/04/22

20:54

Post #: 60643071
Share

Originally posted by JBT999: ↑

Well everyone can clearly see that @Alway cannot comprehend what is written, but just to clarify my position for you again the following should cover it hopefully anyways,

The Changes in Battery Chemistry is Evolving at an Alarming Pace with 3 of The BIGGEST Battery Manufacturers making huge Advances to Eliminate the Dangerous Chemicals that are Responsible for Many Fires within the EV Vehicles being produced, hence the reason these Big Battery Manufactures are looking to Eliminate the use of Nickel and Cobalt with the LFP technology and other Battery Compositions that will make EV Batteries much Safer in the future as well as Producing Cheaper Batteries that are only 2 thirds the cost of the current NCM Battery Technology, then it's a No Brainer for the 3 Biggest Battery Manufacturers to Eliminate the Nickel and Cobalt to produce a Better Product for Consumers, as I have stated before if people want to get something back from this wreck then they need to look at those companies supplying the chemicals that will be driven by the Biggest Battery Manufacturers, unfortunately AUZ MINES will not be part of that growth imo.

Further to the above its simple Economics, but again some here fail to understand that as well, in any event I have never stated Nickel and Cobalt won't still be in demand quite the opposite, but imo it will not be utilised in Electric Vehicles both from a Safety Aspect and a Economic Aspect in the foreseeable future one only needs to be able to comprehend what's written to fully understand what Technologies will be the most sort after in the future.

Expand

Lol

AUZ Price at posting: 22.0¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

There are more pages in this discussion • 62 more messages in this thread...

First 28 Last

Add AUZ (ASX) to my watchlist

(20min delay)
Last 0.8¢		Change -0.001(6.25%)		Mkt cap ! $11.18M

Open	High	Low	Value	Volume
0.8¢	0.8¢	0.8¢	$5.772K	752.7K

Buyers (Bids)

No.	Vol.	Price($)
8	2639604	0.8¢

Sellers (Offers)

Price($)	Vol.	No.
0.6¢	211900	2

View Market Depth

No.	Vol.	Price($)
46	13305467	0.007
35	50624111	0.006
14	31150199	0.005
8	7154750	0.004
2	2400000	0.003

Price($)	Vol.	No.
0.008	1001900	5
0.009	3232695	13
0.010	3538032	23
0.011	4525002	12
0.012	3385705	6

Last trade - 13.49pm 07/10/2024 (20 minute delay)

AUZ (ASX) Chart

Sentimet, none - disclosure, not held - profile not availbee, page-28

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Sentimet, none - disclosure, not held - profile not availbee, page-28

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News